EMA Publishes Human Medicines: Highlights of 2020
EMA has published an overview of its key recommendations in 2020 on the authorization and safety monitoring of medicines for human use.
In 2020, EMA recommended 97 medicines for marketing authorization. Of these, 39 had a new active substance which had never been authorized in the European Union before. The Agency recommended one vaccine and one treatment for COVID-19. The infographic includes figures on the authorization of medicines and a selection of new treatments that represent significant progress in their therapeutic areas.
For more information, click here.
Europe Edges Towards a Health Research Plan
September 28th 2020Europe's research ministers are will meet to attempt to reach agreement on European Union research plans for the next seven years, including a cluster devoted to a broad range of health goals that range from general objectives to subjects of more specific interest to the community.
